-
16 May 2022 | Country Update
Transition measures: Monitoring and surveillance (From January 2022) -
24 March 2021 | Country Update
Transition measures: Monitoring and surveillance -
23 March 2021 | Country Update
Monitoring and surveillance
Monitoring and surveillance
Related Content
Different strategies for tracing the contacts of all COVID-19
positive patients have been considered. A federal legal framework for a
contact tracing application has been studied; the principle is that the
technology has to be open source, only anonymised
data will be used, and Bluetooth technology would be used rather
than geolocation technologies. If different applications are to be used
in the different regions, they should be compatible with each other and
with the federal eHealth platform. On
April 30th, the Belgian Data Protection Authority published some
recommendations and conditions regarding such an application (https://www.autoriteprotectiondonnees.be).
The launch of the contact tracing application occurred on September
30st.
Meanwhile, the solution of ‘human’ tracing (by
telephone) has been preferred to technological tracing, at least for the
first stage. The principle is that Sciensano centralises the data from
all test results (which has
been the case since the beginning of the epidemic); these results
are then dispatched to the health administrations of the federated
entities who organise contact tracing at the local level (telephone
calls to the patients in order to identify all
their contacts).
The Inter-ministerial conference agreed that
identical procedures should be followed in all federated entities and a
working group was created in order to set up a common platform and
tools (see section 5 on Governance).
Two thousand people were recruited, with some of them already
working in the administration, and others through public tenders
launched by the federated entities. From May 4th, call centres have been
set up. The contact tracking system has been gradually
expanded to reach its maximum capacity in the following weeks.
On
May 20th the Inter-ministerial conference also agreed on a framework
for enhanced surveillance of the epidemic in complement of the tracing
(i.e. a barometer of the epidemic).
The aim is to detect any local resurgence of the virus, or a
possible second wave, as soon as possible and to take targeted measures.
It will operate according to a step-by-step principle, i.e. the worse
the situation gets, the more restrictive measures
need to be taken. This barometer will be based mainly, but not
exclusively, on the evolution of the number of hospitalisations. The
development of this second line of defence will be further refined so
that it can be implemented in the short term
by the infectious disease surveillance services at national,
regional and provincial levels.
New restrictions: Monitoring and surveillance
Tracing
has been reinforced since July 29th (July 25th in the catering
industry, i.e. for restaurants,
cafes and bars) and contact information is now requested in specific
situations where there is higher risk of transmission (e.g. in the
catering industry, in wellness and sport centres, etc).
It is
also crucial that test results are made
available to the surveillance agencies very quickly. Rapid transfer
of test results is therefore one of the quality requirements that
laboratories have had to meet since July 20th.
Vaccination surveillance is described in section 3.1.
Related Content
Definition of cases
Sciensano definitions of cases and contacts are as follows:
A
possible case of COVID-19 is a person in whom symptoms of acute lower
or upper respiratory tract infection appear (or worsen in people with
chronic
respiratory symptoms). From April 1st, a new definition was added: a
‘radiologically probable case’ is an individual whose laboratory test
for COVID-19 is negative but for whom the diagnosis of COVID-19 is
nonetheless made on the basis
of an evocative clinical presentation AND a compatible chest CT
scan. On April 17th the High Council for Health published
recommendations on the use of chest CT scans as diagnostic mean. In
summary, despite its high sensitivity, chest CT scans should
not be used as first line diagnostic tool, nor as a systematic
screening tool, and should always be combined with PCR-testing.
(French: https://covid-19.sciensano.be/sites/default/files/Covid19/Avis%20du%20CSS%20concernant%20l%e2%80%99utilisation%20du%20CT-scan.pdf; Dutch: https://covid-19.sciensano.be/sites/default/files/Covid19/Advies%20van%20de%20HGR%20betreffende%20het%20gebruik%20van%20CT-scans.pdf).
From May 4th, the definition of ‘possible cases’
was also enlarged: A ‘possible case’ of COVID-19 is a person with at
least one of the following major symptoms (with no apparent cause):
cough; dyspnoea; chest pain; anosmia or dysgeusia without apparent
cause; OR at least two of the following
minor symptoms (with no apparent cause): fever; muscle aches;
fatigue; rhinitis; sore throat; headache; anorexia; watery diarrhoea;
acute confusion; sudden fall); OR an aggravation of chronic respiratory
symptoms (COPD, asthma, chronic cough, etc.)
with no apparent cause.
A confirmed case of COVID-19 is a person who has a laboratory-confirmed diagnosis of COVID-19;
A
close contact is defined as a family (co-habitant) contact or
equivalent, or a care contact in the context
of aerosol-producing action. Close contacts are mandated to
carefully monitor their health (self-monitoring) for a period of 14
days. In the event of an acute infection of the lower or upper
respiratory tract, the person becomes a possible case and
has to contact his/her GP by phone. A laboratory test is not
necessary (unless he/she is a health care professional with a fever).
The definition of a ‘close contact’ disappeared from April 1st and
reappeared from July 29th, but defined
as contact people can have outside their household for more than 15
minutes, without a distancing of 1.5m and without a facemask. From the
beginning of May, in the context of the contact tracing strategy, a
similar notion was also introduced, i.e.
high-risk contacts.
A high-risk contact is defined as
follows: a person who has cumulative contact of at least 15 minutes
within a distance of less than 1.5 m ("face to face"); a person who was
in the same room/closed environment for more
than 15 minutes with a COVID-19 patient, where a distance of 1.5 m
was not always respected (except when plexiglass divisions were used)
and/or where objects were shared. This includes all classmates for
children under 6 years and neighbours in a
classroom with children under 7 years old; a person who has had
direct physical contact with a COVID-19 patient; a person who has been
in direct physical contact with excretions or body fluids of a COVID-19
patient, such as during kissing and mouth-to-mouth
ventilation, or contact with vomit, bowel movements, mucus, etc.; a
caregiver in contact with a COVID-19 patient during care or medical
treatment or examination within a distance of 1.5m, without the use of
personal protective equipment (according
to protocol/activity); a person who has travelled with a COVID-19
patient for more than 15 minutes, in any means of transport, seated
within two seats (in any direction) from the patient.
Surveillance
Contact
tracing was started
at the beginning of the epidemic, when there were only a few
patients, but it was progressively abandoned given the outburst of
infection.
Sciensano (the national institute for epidemiology)
centralises the data about COVID-19 from the national
reference lab, the hospitals, the residential care centres, the
General Practitioners (GPs) and the network of sentinel GPs (https://www.sciensano.be/en/projects/network-general-practitioners)
and hospitals for the monitoring of flu-like syndrome. (More information on https://www.sciensano.be/en/press-corner/covid-19-figures-sciensano-collects-verifies-and-publishes).
Hospitals
must send a report to Sciensano each day before 11:00 a.m., with their
number of hospitalised COVID-19-patients, deaths and discharges.
Residential
institutions that accommodate people in at-risk groups (e.g. older
people)
must complete a report each day before 11:00 a.m., with the presence
of COVID-19 cases in the facility (among residents and staff), even if
there have been no new cases. The declarations must be encoded via a
centralised and secure application and
sent to Sciensano.
Beginning in April, a controversy arose
in the media about the exact number of deaths in Belgian nursing homes,
which could have been under-reported. The addition of numerous deaths in
nursing homes suddenly increased
Belgium's mortality figures in international comparisons. But it
also appeared that the Belgian data encompassed both the deaths of
patients or residents who were confirmed COVID-19 and those who were
suspected of being infected, whereas other countries
only registered the number of deaths of confirmed cases. Indeed, the
results of the first tests performed in Belgian nursing homes for older
people showed that up to half of the symptomatic residents had a
negative COVID-19 test. The Risk Assessment
Group was then urged to clarify and standardise the registration
procedure.
Ambulatory cases had to be notified to the federated
entities but this obligation was lifted on March 18th (except for
residential institutions, where it remains
more necessary than previously). Only deaths occurring outside the
hospitals have to be notified.
Several online initiatives have
been developed to help physicians monitor the health of their COVID-19
patients at home (see also section
2.2). The anonymised data are made available to researchers and
competent authorities in order to monitor the security measures linked
to the epidemic.
Related Content
References
Regularly updated guidelines for health care professionals and for
residential care can be found on the websites of Sciensano and on the
websites of the Federated entities:
• Sciensano (2020). Coronavirus. Brussels: Sciensano (https://epidemio.wiv-isp.be/ID/Pages/default.aspx, Accessed April 2020) ;
•
Flemish Agency for Care and Health (2020). Uitbraak coronavirus
COVID-19. Brussels: Flemish Agency for Care and Health – Agentschap Zorg
en Gezondheid (https://www.zorg-en-gezondheid.be/covid-19, Accessed April 2020);
• AVIQ (2020). Coronavirus 2019. Charleroi : Agency for a Quality Life-Agence pour une vie de Qualité;
• Iriscare (2020). COVID-19. Brussels: Iriscare (http://www.iriscare.brussels/fr/professionnels/, Accessed April 2020);
• Ostbelgienlive (2020). Coronavirus: Fragen und Antworten. Eupen: Ostbelgienlive (http://www.ostbelgienlive.be/desktopdefault.aspx/tabid-6711/, Accessed April 2020).